M. Sc, CEO.
Andreas Gerward
Andreas has during the last 7 years worked with pharmaceutical development in smaller companies. Since joining Stayble as the CEO in 2014 Andreas has developed the company from selection of the candidate drug through preclinical development and successful clinical trials. Andreas has an engineering background and a master’s in economics and Venture Creation from Chalmers University of Technology.
andreas.gerward@stayble.se +46 (0)730 808 397Below is an overview of the Company’s largest owners as of 30 December 2020
| Name | Total shares | Percentage |
|---|---|---|
| Stiftelsen Chalmers Tekniska Högskola | 1 028 000 | 14,9% |
| Kjell Olmarker | 700 000 | 10,1% |
| ALMI Invest Västsverige AB | 591 016 | 8,6% |
| K-Svets Venture AB | 382 880 | 5,5% |
| Andreas Gerward | 330 000 | 4,8% |
| Robert Joki | 313 329 | 4,5% |
| Advecto AB | 262 400 | 3,8% |
| Avanza Pension | 252 264 | 3,6% |
| Dragfast AB | 200 000 | 2,9% |
| Mattias Münnich | 190 000 | 2,7% |
